iQ HealthTech

Name

iQ HealthTech

Legal name

iQ HealthTech Ltd.

Website

https://iqhealth.tech

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Oncology E-Prescribing Software

NAICS

Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

akta.pro secondary industry

Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)

Keywords

• Chemotherapy e-prescribing
• SACT administration software
• Oncology workflow management
• Clinical decision support
• Electronic prescribing platform

Headquarters

HQ city

Christchurch

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Software Licensing/Subscription: Cloud-based SaaS model providing access to the iQemo platform. Pricing likely subscription-based given enterprise healthcare software market norms and cloud deployment model.
2. Implementation and Support Services: Professional services for deployment, configuration, and ongoing support. Mentioned as a collaborative effort between clinical and technical teams during implementations.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

iQ HealthTech provides iQemo, a cloud-based chemotherapy e-prescribing and electronic administration system that delivers end-to-end electronic administration and recording of Systemic Anti-Cancer Therapy (SACT) for organisations providing cancer treatment. The platform is modular and configurable, integrating with existing hospital systems, medical devices such as smart infusion pumps, and enabling direct ordering from third-party drug manufacturers, and is used by NHS trusts, private hospitals, and international healthcare organisations.

Product overview

iQ HealthTech offers a single unified cloud-based product called iQemo — a chemotherapy e-prescribing and patient care system. iQemo delivers end-to-end electronic administration and recording of Systemic Anti-Cancer Therapy (SACT) for organisations providing cancer treatment. The system features a modular, highly configurable design that integrates with existing hospital systems, medical devices (such as smart infusion pumps), and enables direct ordering from third-party drug manufacturers. The product supports NHS trusts, private hospitals, and international healthcare organisations including implementations in Australia (SA Health).

Differentiator

Problem solved

Functional benefit

Brands

• iQemo: Cloud-based chemotherapy prescribing and patient care system for electronic administration and recording of SACT (Systemic Anti-Cancer Therapy)

Products and services

• iQemo Cloud-based chemotherapy prescribing and patient care system that enables end-to-end electronic administration and recording of Systemic Anti-Cancer Therapy (SACT). It supports NHS trusts, private hospitals, and international healthcare organisations with modular, configurable workflows, integrations to medical devices such as smart infusion pumps, and direct ordering from third-party drug manufacturers.

Quantifiable outcome

• Top 35% in EcoVadis ESG assessment globally

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Altera Digital HealthcoreImplementation/ SI/ Consulting Partner · 1 July 2023Implementation partner for Australian market deployments. Collaboration celebrating successful go-live of iQemo at Mount Gambier and Districts Health Service in South Australia. Part of Altera's digital health ecosystem.
• Microsoft AzurecoreTechnology or IntegrationCloud infrastructure partner for iQemo platform. Successfully completed migration from UKFast to Microsoft Azure, marking a major milestone in improving performance, resilience, and scalability across all supported NHS sites and private healthcare providers. Foundation for future innovation.
• SA Health / Northern Adelaide Local Health NetworkcoreStrategic or Co-development PartnerHealthcare provider partnerships for iQemo deployments in South Australia. Multiple successful implementations including Lyell McEwin Hospital and Mount Gambier and Districts Health Service.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• CIS Oncology: CIS Oncology's ChemoCare is a UK-based chemotherapy prescribing and patient management system widely deployed across NHS trusts, making it the most direct head-to-head competitor to iQemo in the UK SACT e-prescribing market.
• Elekta: Elekta's MOSAIQ is an oncology information system used for medical and radiation oncology workflows, including chemotherapy prescribing, and is a direct competitor to iQemo in hospital oncology software.
• Varian (Siemens Healthineers): Varian's ARIA oncology information system provides medical oncology, radiation oncology, and chemotherapy management functionality and competes directly with iQemo for hospital oncology software contracts.

Broad incumbents

• Epic Systems (Beacon): Epic's Beacon oncology module is a comprehensive oncology management solution embedded in the broader Epic EHR suite; it competes with iQemo especially in NHS trusts pursuing integrated EPR strategies.
• Oracle Health (formerly Cerner): Oracle Health (formerly Cerner) offers oncology functionality within its Millennium EHR, and as a broad incumbent hospital software vendor it overlaps with iQemo in NHS and private hospital deployments.
• Meditech: Meditech is an established EHR vendor with oncology functionality used in hospital settings, and as a broad incumbent it competes with iQemo for integrated clinical system deals in NHS and private hospitals.
• Allscripts (Veradigm): Veradigm (formerly Allscripts) provides EHR and oncology solutions to hospitals and is a broad incumbent that overlaps with iQemo in chemotherapy and clinical workflow management deployments.

Emerging players

• Flatiron Health: Flatiron Health is an oncology-specific data and clinical workflow platform (acquired by Roche) that focuses on cancer care; while primarily US-centric, it represents a similar model of purpose-built oncology technology that competes with iQemo's specialist approach.
• RaySearch Laboratories: RaySearch develops oncology software systems (RayCare) for cancer treatment management, including chemotherapy workflows, and is a comparable specialist vendor competing for advanced oncology information system contracts.

Others

• BD (Becton Dickinson): BD offers medication management and infusion pump solutions that connect with iQemo's smart infusion pump integrations; it is an adjacent ecosystem player in the drug administration workflow rather than a direct prescribing competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/iqhealthtech
• LinkedInlinkedin.com/company/iq-healthtech

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iQ HealthTech